Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort

Arthritis Care and Research

Volumn 59, Issue 2, 2008, Pages 176-180

  Urowitz, M B ^a   Gladman, D ^a   Ibanez D ^a   Fortin, P ^a   Sanchez Guerrero, J ^a   Bae, S ^a   Clarke, A ^a   Bernatsky, S ^a   Gordon, C ^a   Hanly, J ^a   Wallace, D ^a   Isenberg, D ^a   Ginzler, E ^a   Merrill, J ^a   Alarcon G S ^a   Steinsson, K ^a   Petri, M ^a   Dooley, M A ^a   Bruce, I ^a   Manzi, S ^a   Khamashta, M ^a   Ramsey Goldman, R ^a   Zoma, A ^a   Sturfelt, G ^a   Nived, O ^a   Maddison, P ^a   Font, J ^b   Van Vollenhoven, R ^a   Aranow, C ^a   Kalunian, K ^a   Stoll, T ^a   more..

^a TORONTO WESTERN HOSPITAL   (Canada)

^b Toronto Western Hospital IE 409 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE REGISTRY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; ASIA; COHORT STUDIES; CORONARY ARTERY DISEASE; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NORTH AMERICA; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 39449139595     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23353     Document Type: Article

References (18)

1. Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2005;31:329-54.
2. Szekanecz Z, Shoenfeld Y. Lupus and cardiovascular disease: the facts. Lupus 2006;15 Suppl 11:3-10.
3. Urowitz MB, Ibanez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007;34:70-5.
4. Bruce IN, Urowitz MB, Gladman DD, Hallett DC. Natural history of hypercholesterolaemia in systemic lupus erythematosus. J Rheumatol 1999;26:2137-43.
5. Tisseverasinghe A, Lim S, Greenwood C, Urowitz M, Gladman D, Fortin PR. Association between serum total cholesterol and renal outcome in systemic lupus erythematosus. Arthritis Rheum 2006;54:2211-9.
6. Urowitz MB, Gladman DD, Fortin PR, Ibanez D, Sanchez-Guerrero J, Bae SC, et al. Systemic Lupus International Collaborating Clinics (SLICC) inception cohort registry to study risk for atherosclerosis: accumulation of atherosclerotic risk factors over 3 years [abstract]. Arthritis Rheum 2006;54 Suppl 9:S521.
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
8. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
9. Ibanez D, Urowitz MB, Gladman DD. Summarizing disease features over time. I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol 2003;30:1977-82.
10. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
11. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary hearth disease using risk factor categories. Circulation 1998;97:1837-47.
13. Kannel WB, Sorlie P. Some health benefits of physical activity: the Framingham study. Arch Intern Med 1979;139: 857-61.
14. Urowitz MB, Gladman DD, Ibanez D, Berliner Y. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study. Ann Rheum Dis 2006;65:115-7.
15. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
16. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997;145:408-15.
17. Esdaile JM, Abrahamowicz M, Godzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
18. Bessant R, Hingorani A, Patel L, MacGregor A, Isenberg DA, Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 2004;43:924-9.